Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/10240
Title: Carbon ion particle therapy - from accelerators to medical application
Authors: Prokopovich, DA
Keywords: Australia
Therapy
Protons
ANSTO
Accelerator experimental facilities
Targets
Tissues
Radiation doses
Issue Date: 6-Oct-2107
Publisher: Australian Nuclear Science and Technology Organisation
Citation: Prokopovich. D. (2017). Carbon ion particle therapy - from accelerators to medical application. Presentation to the ANA 2017 Conference, 6 October 2017, at UTS, Ultimo, Australia.
Abstract: Particle therapy is gaining increasing usage internationally with particle therapy now being routinely used as a part of the radiotherapy protocols for cancer in several countries. Australia currently has several particle therapy proposals in development, including recent funding for a South Australian proton therapy and research facility. ANSTO and others are supporting the establishment of a National Particle Treatment and Research Centre. Unlike conventional Xray therapy, which uses accelerated electrons to generate X-rays, particle therapy uses a particle accelerator to fire ions directly in a highly precise beam into the patient to spare healthy tissue and ensure conformity of the dose delivery. Carbon ion therapy facilities use accelerated 12C ions because the carbon ions have a higher Relative Biological Effectiveness (RBE) when compared to X-rays or protons, as well as a better dose conformation to a tumour. An overview of different accelerator technologies and treatment delivery methods will be given as well as highlights of the latest developments for patient dose delivery technology.
URI: https://apo.ansto.gov.au/dspace/handle/10238/10240
Appears in Collections:Conference Publications

Files in This Item:
File Description SizeFormat 
ANA2017-Prokopovich-ab.pdf142.17 kBAdobe PDFThumbnail
View/Open
ANA2017-Program.pdf244.31 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.